Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06492915
What this trial is testing

Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Chipscreen Biosciences, Ltd. 42
Not applicableUnknownNCT03138213
What this trial is testing

Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy

Who this might be right for
Pancreatic Ductal AdenocarcinomaSurgeryPeriampullary Cancer
Tongji Hospital 656
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Early research (Phase 1)Active Not RecruitingNCT03875820
What this trial is testing

Phase I Trial of Defactinib and VS-6766.

Who this might be right for
NSCLCLow Grade Serous Ovarian CancerEndometrioid Carcinoma+1 more
Institute of Cancer Research, United Kingdom 87
Not applicableUnknownNCT03951324
What this trial is testing

Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study

Who this might be right for
Biliary StricturePancreas CancerCholangiocarcinoma+14 more
Innovative Digestive Health Education and Research Inc 40
Not applicableUnknownNCT06151691
What this trial is testing

Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 51
Testing effectiveness (Phase 2)Looking for participantsNCT06405490
What this trial is testing

NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC

Who this might be right for
Nanoliposomal IrinotecanCadonilimabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT04911816
What this trial is testing

Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Pancreas
West Virginia University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05825066
What this trial is testing

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma
Wake Forest University Health Sciences 64
Not applicableUnknownNCT01919151
What this trial is testing

Micrometastasis in Gastrointestinal Cancer

Who this might be right for
Pancreatic AdenocarcinomaColorectal Cancer
Oslo University Hospital 500
Not applicableUnknownNCT05095831
What this trial is testing

EUS Shear Wave for Solid Pancreatic Lesions.

Who this might be right for
Pancreas NeoplasmPancreatitisPancreatitis, Acute+2 more
Instituto Ecuatoriano de Enfermedades Digestivas 25
Large-scale testing (Phase 3)Ended earlyNCT00227617
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more
University of California, San Francisco 36
Not applicableUnknownNCT05248750
What this trial is testing

Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreas Cancer
Catholic University of the Sacred Heart 250
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Early research (Phase 1)Active Not RecruitingNCT05209074
What this trial is testing

Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Cancer
Case Comprehensive Cancer Center 16
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Large-scale testing (Phase 3)UnknownNCT00075452
What this trial is testing

Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Looking for participantsNCT05451043
What this trial is testing

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Who this might be right for
Pancreatic CancerHepatocellular CancerBiliary Tract Cancer+1 more
AHS Cancer Control Alberta 62
Not applicableLooking for participantsNCT06552078
What this trial is testing

Activation of Biobank Registry for Bilio-pancreatic Diseases

Who this might be right for
PancreatitisPancreatic DiseaseNon-Neoplastic Pancreatic Disorder+1 more
IRCCS San Raffaele 2,000
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Next Page